Abstract
Gastric infection with Helicobacter pylori results in chronic active gastritis and in some individuals is associated with complications such as peptic ulceration and gastric cancers. A balance between bacterial factors and host responses may determine disease outcome. The mouse-adapted H. pylori strain SS1 has been utilized as a model to study disease pathogenesis. Although chronic gastritis is observed in this murine model of H. pylori infection, other complications of disease seen in the human host (such as peptic ulceration) are not identified. The objectives of this study were to characterize virulence factors of the mouse-adapted H. pylori strain SS1 and determine host responses to infection. Vacuolating cytotoxin activity of H. pylori strain SS1 was determined after incubation of HEp-2 cells with culture supernatant for 24 hr. Polymerase chain reaction was performed to detect the presence of the cagA and cagE genes. Chemokine responses from human gastric epithelial cells infected with H. pylori SS1 were assessed by measurement of the concentration of interleukin-8 in cell-free supernatants. C57BL/6 and gld mice were infected with strain SS1 or sham-infected. Eight weeks following infection, gastric tissues were obtained for histological analysis and surface hydrophobicity was measured by axisymmetric drop-shape analysis. H. pylori strain SS1 was cytotoxin negative, cagA positive, and cagE positive, but induced only a modest interleukin-8 response (684 ± 140 pg/ml) from AGS gastric epithelial cells in comparison to a clinical isolate (4170 ± 410 pg/ml, P < 0.0005). Increased inflammation was observed in the stomachs of H. pylori strain SS1-infected animals compared to uninfected controls. Gastritis was not associated with any disease complications. Despite mucosal inflammation, infected mice did not demonstrate alterations in gastric surface hydrophobicity (42.2° ± 2.2° and 41.4° ± 3.2° for C57BL/6 and gld, respectively) compared to uninfected mice (43.2° ± 2.3° and 39.5° ± 1.6°, respectively). In conclusion, murine infection with H. pylori SS1, which contains putative bacterial virulence factors, results in gastric inflammation. However, the mucosal changes are not associated with alterations in surface hydrophobicity. Therefore, the mouse model of infection with H. pylori, strain SS1 may not serve as an entirely appropriate model to study host factors associated with disease complications.
Article PDF
Similar content being viewed by others
REFERENCES
Ota H, Genta RM: Morphological characterization of the gastric mucosa during infection with H. pylori. In The Immunobiology of H. pylori. PB Ernst, P Michetti, PD Smith, (eds). Philadelphia, Lippincott-Raven, 1997, pp 15–27
Blaser MJ, Chyou PH, Nomura A: Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 55:562–565, 1995
Fennerty MB: Is the only good H. pylori a dead H. pylori? Gastroenterology 111:1773–1774, 1996
Day AS, Sherman PM: Understanding disease outcome following acquisition of Helicobacter pylori infection during childhood. Can J Gastroenterol 13:229–234, 1999
Day AS, Jones NL, Lynett JT, Jennings HA, Fallone CA, Beech R, Sherman P: cagE is a virulence factor associated with Helicobacter pylori induced duodenal ulceration in children. J Infect Dis 181:1370–1375, 2000
Crabtree JE: Virulence factors of H. pylori and their effect on chemokine production. In The Immunobiology of H. pylori. PB Ernst, P Michetti, PD Smith (eds). Philadelphia, Lippincott-Raven, 1997, pp 101–112
Hills BA: Gastric mucosal barrier: Evidence for Helicobacter pylori ingesting gastric surfactant and deriving protection from it. Gut 34:588–593, 1993
Hills BA: Gastric surfactant and the hydrophobic mucosal barrier. Gut 39:621–624, 1996
Lichtenberger LM: The hydrophobic barrier properties of gastrointestinal mucus. Annu Rev Physiol 57:565–583, 1995
Asante M, Ahmed H, Patel P, Davis T, Finlayson C, Mendall M, Northfield T: Gastric mucosal hydrophobicity in duodenal ulceration: Role of Helicobacter pylori infection density and mucus lipids. Gastroenterology 113:449–454, 1997
Lee A, Fox JG: Animal models for vaccine development. In The Immunobiology of H. pylori. PB Ernst, P Michetti, PD Smith, (eds). Philadelphia, Lippincott-Raven, 1997, pp 255–271
Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF: A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain. Gastroenterology 112:1386–1397, 1997
van Doorn NE, Namavar F, Sparrius M, Stoof J, van Rees EP, van Doorn LJ, Vandenbroucke-Grauls CM: Helicobacter pylori-associated gastritis in mice is host and strain specific. Infect Immun 67:3040–3046, 1999
Jones N, Day A, Wu G, Islur A, Shannon P, Sherman P. Enhanced disease severity in Helicobacter pylori-infected gld mice deficient in Fas signaling. Can J Gastroenterol 13(suppl B):211B, 1999
Loeb M, Jayaratne P, Jones N, Sihoe A, Sherman P: Lack of correlation between vacuolating cytotoxin activity, cagA gene in Helicobacter pylori, and peptic ulcer disease in children. Eur J Clin Microbiol Infect Dis 17:653–656, 1998
Drumm B, Sherman P: Long-term storage of Campylobacter pylori. J Clin Microbiol 27:1655–1656, 1989
Crowe SE, Alvarez L, Dytoc M, Hunt RH, Muller M, Sherman P, Patel J, Jin Y, Ernst PB: Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 108:65–74, 1995
Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K: Current Protocols in Molecular Biology. New York, John Wiley & Sons, 1987
Nagata S: Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: A lesson from the mouse model. J Hum Genet 43:2–8, 1998
Spychal RT, Marrero JM, Saverymuttu SH, Northfield TC: Measurement of the surface hydrophobicity of human gastrointestinal mucosa. Gastroenterology 97:104–111, 1989
Mack DR, Sherman PM: Hydrophobicity and the gastrointestinal tract: methods of determination, its source, and implications for bacterial adherence. Colloids Surfaces B: Biointerfaces 15:355–363, 1999
Chung C, van Hoof L, Policova Z, Beharry S, Sherman PM, Neumann AW, Durie P: Surface hydrophobicity is increased in the ileum and proximal colon of cystic fibrosis mice. Pediatr Res 46:174–178, 1999
Jenks PJ, Labigne A, Ferrero RL: Exposure to metronidazole in vivo readily induces resistance in Helicobacter pylori and reduces the efficacy of eradication therapy in mice. Antimicrob Agents Chemother 43:777–781, 1999
Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR: Cytotoxic activity in broth-culture filtrates of Camplyobacter pylori. J Med Microbiol 26:93–99, 1988
Figura N, Guglielmetti P, Rossolini A, Barberi A, Cusi G, Musmanno RA, Russi M, Quaranta S: Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 27:225–226, 1989
Miehlke S, Kibler K, Kim JG, Figura N, Small SM, Graham DY, Go MF: Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol 91:1322–1325, 1996
Ogura K, Kanai F, Maeda S, Yoshida H, Ogura M, Lan KH, Hirota K, Kawabe T, Shiratori Y, Omata M: High prevalence of cytotoxin positive Helicobacter pylori in patients unrelated to the presence of peptic ulcers in Japan. Gut 41:463–468, 1997
Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ: Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 338:332–335, 1991
Graham DY, Genta RM, Graham DP, Crabtree JE: Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: Lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. J Clin Pathol 49:829–832, 1996
Atherton JC, Peek RM Jr, Tham KT, Cover TL, Blaser MJ: Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 112:92–99, 1997
Celik J, Su B, Tiren U, Finkel Y, Thoresson AC, Engstrand L, Sandstedt B, Bernander S, Normark S: Virulence and colonization-associated properties of Helicobacter pylori isolated from children and adolescents. J Infect Dis 177:247–252, 1998
van Doorn LJ, Figueiredo C, Sanna R, Blaser MJ, Quint WGV: Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes. J Clin Microbiol 37:2306–2311, 1999
Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A: cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 93:14648–14653, 1996
Jenks PJ, Megraud F, Labigne A: Clinical outcome after infection with Helicobacter pylori does not appear to be reliably predicted by the presence of any of the genes of the cag pathogenicity island. Gut 43:752–758, 1998
Bjorkholm B, Engstrand L, Rubio C, Falk P: cag pathogenicity island is required for colonization of Helicobacter pylori in a transgenic mouse model. 99th Annual Meeting of the American Society of Microbiology, Chicago, Illinois, USA. D/B 183:244, 1999 (Abstract)
Fisher KJ, Kolesnikow T, Mitchell HM, Wilson JE, O'Rourke J, Lee A: cagE is essential for gastric colonisation in the Sydney strain mouse model. Gut 45(suppl III):A24, 1999 (abstract)
Tummuru MK, Sharma SA, Blaser MJ: Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol 18:867–876, 1995
Wolpe SD, Sherry B, Juers D, Davatelis G, Yurt RW, Cerami A: Identification and characterization of macrophage inflammatory protein-2. Proc Natl Acad Sci USA 86:612–616, 1989
Hackelsberger A, Platzer U, Nilius M, Schultze V, Gunther T, Dominguez-Munoz JE, Malfertheiner P: Age and Helicobacter pylori decrease gastric mucosal surface hydrophobicity independently. Gut 43:465–469, 1998
Spychal RT, Goggin PM, Marrero JM, Saverymuttu SH, Yu CW, Corbishley CM, Maxwell JD, Northfield TC: Surface hydrophobicity of gastric mucosa in peptic ulcer disease. Relationship to gastritis and Campylobacter pylori infection. Gastroenterology 98:1250–1254, 1990
Go MF, Lew GM, Lichtenberger LM, Genta RM, Graham DY: Gastric mucosal hydrophobicity and Helicobacter pylori: Response to antimicrobial therapy. Am J Gastroenterol 88:1362–1365, 1993
Li H, Kalies I, Mellgard B, Helander HF: A rat model of chronic Helicobacter pylori infection. Studies of epithelial cell turnover and gastric ulcer healing. Scand J Gastroenterol 33:370–378, 1998
Lee A: Animal models for host-pathogen interaction studies. Br Med Bull 54:163–173, 1998
Gold BD, Islur P, Policova Z, Czinn S, Neumann AW, Sherman PM: Surface properties of Helicobacter mustelae and ferret gastrointestinal mucosa. Clin Invest Med 19:92–100, 1996
Lichtenberger LM, Dial EJ, Ottlecz A, Romero JJ, Lechago J, Fox JG: Attenuation of hydrophobic phospholipid barrier is an early event in Helicobacter felis-induced gastritis in mice. Dig Dis Sci 44:108–115, 1999
Dey A, Yokota K, Kobayashi K, Oguma K, Hirai Y, Akagi T: Antibody and cytokine responses in Helicobacter pylori-infected various mouse strains. Acta Med Okayama 52:41–48, 1998
Mack DR, Neumann AW, Policova Z, Sherman PM: Surface hydrophobicity of the intestinal tract. Am J Physiol 262:G171–G177, 1992
Ikeno T, Ota H, Sugiyama A, Ishida K, Katsuyama T, Genta RM, Kawasaki S: Helicobacter pylori-induced chronic active gastritis, intestinal metaplasia, and gastric ulcer in Mongolian gerbils. Am J Pathol 154:951–960, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Day, A.S., Jones, N.L., Policova, Z. et al. Characterization of Virulence Factors of Mouse-Adapted Helicobacter pylori Strain SS1 and Effects on Gastric Hydrophobicity. Dig Dis Sci 46, 1943–1951 (2001). https://doi.org/10.1023/A:1010691216207
Issue Date:
DOI: https://doi.org/10.1023/A:1010691216207